{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:18Z","timestamp":1791924738361,"version":"4.3.4"},"reference-count":56,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.5582\/bst.2024.01365","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:12:18Z","timestamp":1737583938000},"page":"1-9","source":"Crossref","is-referenced-by-count":17,"title":["Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of &lt;i&gt;APOE-\u03b54 &lt;\/i&gt;"],"prefix":"10.5582","volume":"19","author":[{"given":"Ya-nan","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Karako","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Song","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."},{"name":"National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Deng Y, Wang H, Gu K, Song P. Alzheimer&apos;s disease with frailty: Prevalence, screening, assessment, intervention strategies and challenges. Biosci Trends. 2023; 17:283-292.","DOI":"10.5582\/bst.2023.01211"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wang C, Song P, Niu Y. The management of dementia worldwide: A review on policy practices, clinical guidelines, end-of-life care, and challenge along with aging population. Biosci Trends. 2022; 16:119-129.","DOI":"10.5582\/bst.2022.01042"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodr\u00edguez I, Cadena-Su\u00e1rez AR, S\u00e1nchez-Garibay C, Pozo-Molina G, M\u00e9ndez-Catal\u00e1 CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Mu\u00f1oz J, Soto-Rojas LO. Alzheimer&apos;s disease: An updated overview of its genetics. Int J Mol Sci. 2023; 24:3754.","DOI":"10.3390\/ijms24043754"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F. Molecular mechanisms of neuroinflammation in aging and Alzheimer&apos;s disease progression. Int J Mol Sci. 2023; 24:1869.","DOI":"10.3390\/ijms24031869"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ma YN, Hu X, Karako K, Song P, Tang W, Xia Y. Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer&apos;s disease. Biosci Trends. 2024. doi: 10.5582\/bst.2024.01306.","DOI":"10.5582\/bst.2024.01306"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, Levey AI, Johnson ECB. Multi-platform proteomic analysis of Alzheimer&apos;s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther. 2022; 14:174.","DOI":"10.1186\/s13195-022-01113-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sun YY, Wang Z, Huang HC. Roles of ApoE4 on the pathogenesis in Alzheimer&apos;s disease and the potential therapeutic approaches. Cell Mol Neurobiol. 2023; 43:3115-3136.","DOI":"10.1007\/s10571-023-01365-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bhalala OG, Watson R, Yassi N. Multi-omic blood biomarkers as dynamic risk predictors in late-onset Alzheimer&apos;s disease. Int J Mol Sci. 2024; 25:1231.","DOI":"10.3390\/ijms25021231"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001; 294:1354-1357.","DOI":"10.1126\/science.294.5545.1354"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gouveia Roque C, Phatnani H, Hengst U. The broken Alzheimer&apos;s disease genome. Cell Genom. 2024; 4:100555.","DOI":"10.1016\/j.xgen.2024.100555"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A, Kivimaki M, Singh-Manoux A, Dumurgier J. The association of APOE epsilon4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimers Res Ther. 2021; 13:5.","DOI":"10.1186\/s13195-020-00740-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fruhwurth S, Zetterberg H, Paludan SR. Microglia and amyloid plaque formation in Alzheimer&apos;s disease - Evidence, possible mechanisms, and future challenges. J Neuroimmunol. 2024; 390:578342.","DOI":"10.1016\/j.jneuroim.2024.578342"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006; 63:168-174.","DOI":"10.1001\/archpsyc.63.2.168"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&apos;s disease in late onset families. Science. 1993; 261:921-923.","DOI":"10.1126\/science.8346443"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. 2020 Alzheimer&apos;s disease facts and figures. Alzheimers Dement. 2020; 10. doi: 10.1002\/alz.12068.","DOI":"10.1002\/alz.12068"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mouchard A, Boutonnet MC, Mazzocco C, Biendon N, Macrez N, Neuro CEBNN. ApoE-fragment\/Abeta heteromers in the brain of patients with Alzheimer&apos;s disease. Sci Rep. 2019; 9:3989.","DOI":"10.1038\/s41598-019-40438-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hauser PS, Narayanaswami V, Ryan RO. Apolipoprotein E: From lipid transport to neurobiology. Prog Lipid Res. 2011; 50:62-74.","DOI":"10.1016\/j.plipres.2010.09.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hashimoto T, Serrano-Pozo A, Hori Y, <i>et al<\/i>. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide. J Neurosci. 2012; 32:15181-15192.","DOI":"10.1523\/JNEUROSCI.1542-12.2012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Serrano-Pozo A, Qian J, Monsell SE, Betensky RA, Hyman BT. APOE epsilon2 is associated with milder clinical and pathological Alzheimer disease. Ann Neurol. 2015; 77:917-929.","DOI":"10.1002\/ana.24369"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kara E, Marks JD, Roe AD, Commins C, Fan Z, Calvo-Rodriguez M, Wegmann S, Hudry E, Hyman BT. A flow cytometry-based <i>in vitro<\/i> assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type. J Biol Chem. 2018; 293:13247-13256.","DOI":"10.1074\/jbc.RA117.001388"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mok KK, Yeung SH, Cheng GW, Ma IW, Lee RH, Herrup K, Tse KH. Apolipoprotein E epsilon4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. J Neurochem. 2023; 165:55-75.","DOI":"10.1111\/jnc.15748"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. Amyloid-beta protein dimers isolated directly from Alzheimer&apos;s brains impair synaptic plasticity and memory. Nat Med. 2008; 14:837-842.","DOI":"10.1038\/nm1782"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 2007; 27:2866-2875.","DOI":"10.1523\/JNEUROSCI.4970-06.2007"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tachibana M, Holm ML, Liu CC, <i>et al<\/i>. APOE4-mediated amyloid-beta pathology depends on its neuronal receptor LRP1.J Clin Invest. 2019; 129:1272-1277.","DOI":"10.1172\/JCI124853"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, Verghese PB, Herz J, Holtzman DM, Zlokovic BV. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-beta42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018; 13:57.","DOI":"10.1186\/s13024-018-0286-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Moon WJ, Lim C, Ha IH, Kim Y, Moon Y, Kim HJ, Han SH. Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia. J Cereb Blood Flow Metab. 2021; 41:1351-1361.","DOI":"10.1177\/0271678X20952012"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J.2002; 21:5691-5700.","DOI":"10.1093\/emboj\/cdf568"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kang SS, Ahn EH, Liu X, Bryson M, Miller GW, Weinshenker D, Ye K. ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer&apos;s disease. Acta Neuropathol. 2021; 142:139-158.","DOI":"10.1007\/s00401-021-02315-1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Barthelemy NR, Li Y, Joseph-Mathurin N, <i>et al<\/i>. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer&apos;s disease. Nat Med. 2020; 26:398-407.","DOI":"10.1038\/s41591-020-0781-z"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Iannucci J, Sen A, Grammas P. Isoform-specific effects of apolipoprotein E on markers of inflammation and toxicity in brain glia and neuronal cells <i>in vitro<\/i>. Curr Issues Mol Biol. 2021; 43:215-225.","DOI":"10.3390\/cimb43010018"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Salami A, Adolfsson R, Andersson M, Blennow K, Lundquist A, Adolfsson AN, Scholl M, Zetterberg H, Nyberg L. Association of APOE varepsilon4 and plasma p-tau181 with preclinical Alzheimer&apos;s disease and longitudinal change in hippocampus function. J Alzheimers Dis. 2022; 85:1309-1320.","DOI":"10.3233\/JAD-210673"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG. Microvascular injury and blood-brain barrier leakage in Alzheimer&apos;s disease. Neurobiol Aging. 2007; 28:977-986.","DOI":"10.1016\/j.neurobiolaging.2006.05.016"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Stannard AK, Riddell DR, Sacre SM, Tagalakis AD, Langer C, von Eckardstein A, Cullen P, Athanasopoulos T, Dickson G, Owen JS. Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem. 2001; 276:46011-46016.","DOI":"10.1074\/jbc.M104812200"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Salloway S, Gur T, Berzin T, Tavares R, Zipser B, Correia S, Hovanesian V, Fallon J, Kuo-Leblanc V, Glass D, Hulette C, Rosenberg C, Vitek M, Stopa E. Effect of APOE genotype on microvascular basement membrane in Alzheimer&apos;s disease. J Neurol Sci. 2002; 203-204:183-187.","DOI":"10.1016\/S0022-510X(02)00288-5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhou X, Shi Q, Zhang X, Gu L, Li J, Quan S, Zhao X, Li Q. ApoE4-mediated blood-brain barrier damage in Alzheimer&apos;s disease: Progress and prospects. Brain Res Bull. 2023; 199:110670.","DOI":"10.1016\/j.brainresbull.2023.110670"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, Van Eldik LJ, LaDu MJ. APOE-modulated Abeta-induced neuroinflammation in Alzheimer&apos;s disease: Current landscape, novel data, and future perspective. J Neurochem. 2015; 133:465-488.","DOI":"10.1111\/jnc.13072"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Krasemann S, Madore C, Cialic R, <i>et al<\/i>. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017; 47:566-581 e569.","DOI":"10.1016\/j.immuni.2017.08.008"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Li X, Montine KS, Keene CD, Montine TJ. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. FASEB J. 2015; 29:1754-1762.","DOI":"10.1096\/fj.14-262683"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Anderson EL, Williams DM, Walker VM, Davies NM. Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers. Sci Rep. 2022; 12:1057.","DOI":"10.1038\/s41598-022-05225-8"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Duro MV, Ebright B, Yassine HN. Lipids and brain inflammation in APOE4-associated dementia. Curr Opin Lipidol. 2022; 33:16-24.","DOI":"10.1097\/MOL.0000000000000801"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Wang YY, Ge YJ, Tan CC, Cao XP, Tan L, Xu W. The proportion of APOE4 carriers among non-demented individuals: A pooled analysis of 389,000 community-dwellers. J Alzheimers Dis. 2021; 81:1331-1339.","DOI":"10.3233\/JAD-201606"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. 2022 Alzheimer&apos;s disease facts and figures. Alzheimers Dement. 2022; 18:700-789.","DOI":"10.1002\/alz.12638"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Di Marco LY, Marzo A, Munoz-Ruiz M, Ikram MA, Kivipelto M, Ruefenacht D, Venneri A, Soininen H, Wanke I, Ventikos YA, Frangi AF. Modifiable lifestyle factors in dementia: A systematic review of longitudinal observational cohort studies. J Alzheimers Dis. 2014; 42:119-135.","DOI":"10.3233\/JAD-132225"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: A longitudinal study from the Kungsholmen project. Am J Epidemiol. 2002; 155:1081-1087.","DOI":"10.1093\/aje\/155.12.1081"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Wang HX, Xu W, Pei JJ. Leisure activities, cognition and dementia. Biochim Biophys Acta. 2012; 1822:482-491.","DOI":"10.1016\/j.bbadis.2011.09.002"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Staff RT, Hogan MJ, Williams DS, Whalley LJ. Intellectual engagement and cognitive ability in later life (the &quot;use it or lose it&quot; conjecture): Longitudinal, prospective study. BMJ. 2018; 363:k4925.","DOI":"10.1136\/bmj.k4925"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Najar J, Ostling S, Gudmundsson P, Sundh V, Johansson L, Kern S, Guo X, Hallstrom T, Skoog I. Cognitive and physical activity and dementia: A 44-year longitudinal population study of women. Neurology. 2019; 92:e1322-e1330.","DOI":"10.1212\/WNL.0000000000007021"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Zhang YR, Yang L, Wang HF, Wu BS, Huang SY, Cheng W, Feng JF, Yu JT. Immune-mediated diseases are associated with a higher incidence of dementia: A prospective cohort study of 375,894 individuals. Alzheimers Res Ther. 2022; 14:130.","DOI":"10.1186\/s13195-022-01072-x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Mhatre-Winters I, Eid A, Han Y, Tieu K, Richardson JR. Sex and APOE genotype alter the basal and induced inflammatory states of primary microglia from APOE targeted replacement mice. Int J Mol Sci. 2022; 23:9829.","DOI":"10.3390\/ijms23179829"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer&apos;s Disease Neuroimaging Initiative I. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75:563-573.","DOI":"10.1002\/ana.24135"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Chene G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, Seshadri S. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement. 2015; 11:310-320.","DOI":"10.1016\/j.jalz.2013.10.005"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Neu SC, Pa J, Kukull W, <i>et al<\/i>. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis. JAMA Neurol. 2017; 74:1178-1189.","DOI":"10.1001\/jamaneurol.2017.2188"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction. Neurology. 2000; 54:1949-1954.","DOI":"10.1212\/WNL.54.10.1949"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Frick EA, Emilsson V, Jonmundsson T, <i>et al<\/i>. Serum proteomics reveal APOE-epsilon4-dependent and APOE-epsilon4-independent protein signatures in Alzheimer&apos;s disease. Nat Aging. 2024; 4:1446-1464.","DOI":"10.1038\/s43587-024-00693-1"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Sattlecker M, Kiddle SJ, Newhouse S, <i>et al<\/i>. Alzheimer&apos;s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. 2014; 10:724-734.","DOI":"10.1016\/j.jalz.2013.09.016"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Sattlecker M, Khondoker M, Proitsi P, Williams S, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Dobson RJ. Longitudinal protein changes in blood plasma associated with the rate of cognitive decline in Alzheimer&apos;s disease. J Alzheimers Dis. 2016; 49:1105- 1114.","DOI":"10.3233\/JAD-140669"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/1\/19_2024.01365\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T04:18:06Z","timestamp":1741407486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/1\/19_2024.01365\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2024.01365","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"2024.01365"}}